Inhibition of high glucose-induced VEGF release in retinal ganglion cells by RNA interference targeting G protein-coupled receptor 91

Experimental Eye Research

Volumn 109, Issue , 2013, Pages 31-39

  Hu, Jianyan ^a   Wu, Qiang ^a   Li, Tingting ^a   Chen, Yongdong ^a   Wang, Shuai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Diabetic retinopathy; G protein coupled receptor 91; Lentivirus; Mitogen activated protein kinase signaling pathway; Retinal ganglion cells; Small hairpin RNA; Vascular endothelial growth factor

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 91; GLUCOSE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SUCCINIC ACID; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EXPRESSION VECTOR; GENE SILENCING; IN VITRO STUDY; LENTIVIRINAE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA GANGLION CELL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; GLUCOSE; LENTIVIRUS; MACACA MULATTA; MAP KINASE SIGNALING SYSTEM; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RETINAL GANGLION CELLS; RETINAL VESSELS; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874726758     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.01.011     Document Type: Article

References (39)

1. Abbas-Terki T., Blanco-Bose W., Deglon N., Pralong W., Aebischer P. Lentiviral-mediated RNA interference. Hum. Gene Ther. 2002, 13:2197-2201.
2. Adamis A.P., Miller J.W., Bernal M.T., D'Amico D.J., Folkman J., Yeo T.K., Yeo K.T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 1994, 118:445-450.
3. 2+ transient and cardiomyocyte viability through PKA-dependent pathway. Cell Calcium 2010, 47:37-46.
4. Barber A.J., Lieth E., Khin S.A., Antonetti D.A., Buchanan A.G., Gardner T.W. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest. 1998, 102:783-791.
5. Cheung C.M., Vania M., Ang M., Chee S.P., Li J. Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy. Mol. Vis. 2012, 18:830-837.
6. Cheung N., Mitchell P., Wong T.Y. Diabetic retinopathy. Lancet 2010, 376:124-136.
7. Clermont A.C., Cahill M., Salti H., Rook S.L., Rask-Madsen C., Goddard L., Wong J.S., Bursell D., Bursell S.E., Aiello L.P. Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics. Invest. Ophthalmol. Vis. Sci. 2006, 47:2701-2708.
8. DeNiro M., Al-Halafi A., Al-Mohanna F.H., Alsmadi O., Al-Mohanna F.A. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy. Mol. Pharmacol. 2010, 77:348-367.
9. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
10. Hammes H.P., Federoff H.J., Brownlee M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol. Med. 1995, 1:527-534.
11. He W., Miao F.J., Lin D.C., Schwandner R.T., Wang Z., Gao J., Chen J.L., Tian H., Ling L. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 2004, 429:188-193.
12. Kilic U., Kilic E., Jarve A., Guo Z., Spudich A., Bieber K., Barzena U., Bassetti C.L., Marti H.H., Hermann D.M. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J. Neurosci. 2006, 26:12439-12446.
13. Laron M., Bearse M.A., Bronson-Castain K., Jonasdottir S., King-Hooper B., Barez S., Schneck M.E., Adams A.J. Interocular symmetry of abnormal multifocal electroretinograms in adolescents with diabetes and no retinopathy. Invest. Ophthalmol. Vis. Sci. 2012, 53:316-321.
14. Layton C.J., Becker S., Osborne N.N. The effect of insulin and glucose levels on retinal glial cell activation and pigment epithelium-derived fibroblast growth factor-2. Mol. Vis. 2006, 12:43-54.
15. Li F., Xu H., Zeng Y., Yin Z.Q. Overexpression of fibulin-5 in retinal pigment epithelial cells inhibits cell proliferation and migration and downregulates VEGF, CXCR4, and TGFB1 expression in cocultured choroidal endothelial cells. Curr. Eye Res. 2012, 37:540-548.
16. Malecaze F., Clamens S., Simorre-Pinatel V., Mathis A., Chollet P., Favard C., Bayard F., Plouet J. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch. Ophthalmol. 1994, 112:1476-1482.
17. Manjunath N., Wu H., Subramanya S., Shankar P. Lentiviral delivery of short hairpin RNAs. Adv. Drug Deliv. Rev. 2009, 61:732-745.
18. Martin P.M., Roon P., Van Ells T.K., Ganapathy V., Smith S.B. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest. Ophthalmol. Vis. Sci. 2004, 45:3330-3336.
19. McBain V.A., Robertson M., Muckersie E., Forrester J.V., Knott R.M. High glucose concentration decreases insulin-like growth factor type 1-mediated mitogen-activated protein kinase activation in bovine retinal endothelial cells. Metab. Clin. Exp. 2003, 52:547-551.
20. Miranda S., Gonzalez-Rodriguez A., Garcia-Ramirez M., Revuelta-Cervantes J., Hernandez C., Simo R., Valverde A.M. Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions. J. Cell. Physiol. 2012, 227:2352-2362.
21. Mohan N., Monickaraj F., Balasubramanyam M., Rema M., Mohan V. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. J. Diabet. Complicat. 2012, 26:435-441.
22. Nilsson M., von W.G., Wanger P., Martin L. Early detection of macular changes in patients with diabetes using Rarebit Fovea Test and optical coherence tomography. Br. J. Ophthalmol. 2007, 91:1596-1598.
23. Nishijima K., Ng Y.S., Zhong L., Bradley J., Schubert W., Jo N., Akita J., Samuelsson S.J., Robinson G.S., Adamis A.P., Shima D.T. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am. J. Pathol. 2007, 171:53-67.
24. Nishitsuji H., Ikeda T., Miyoshi H., Ohashi T., Kannagi M., Masuda T. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Microbes Infect. 2004, 6:76-85.
25. Nolan C.J., Damm P., Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011, 378:169-181.
26. Ola M.S., Moore P., Maddox D., El-Sherbeny A., Huang W., Roon P., Agarwal N., Ganapathy V., Smith S.B. Analysis of sigma receptor (sigmaR1) expression in retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice. Brain Res. Mol. Brain Res. 2002, 107:97-107.
27. Oshitari T., Yoshida-Hata N., Yamamoto S. Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose. Brain Res. 2010, 1346:43-51.
28. Ozawa Y., Kurihara T., Sasaki M., Ban N., Yuki K., Kubota S., Tsubota K. Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model. Exp. Diabetes Res. 2011, 2011:108328.
29. Perrone L., Devi T.S., Hosoya K., Terasaki T., Singh L.P. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J. Cell. Physiol. 2009, 221:262-272.
30. Peti-Peterdi J. High glucose and renin release: the role of succinate and GPR91. Kidney Int. 2010, 78:1214-1217.
31. Santiago A.R., Cristovao A.J., Santos P.F., Carvalho C.M., Ambrosio A.F. High glucose induces caspase-independent cell death in retinal neural cells. Neurobiol. Dis. 2007, 25:464-472.
32. Sapieha P., Sirinyan M., Hamel D., Zaniolo K., Joyal J.S., Cho J.H., Honore J.C., Kermorvant-Duchemin E., Varma D.R., Tremblay S., Leduc M., Rihakova L., Hardy P., Klein W.H., Mu X., Mamer O., Lachapelle P., Di P.A., Beausejour C., Andelfinger G., Mitchell G., Sennlaub F., Chemtob S. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat. Med. 2008, 14:1067-1076.
33. Toma I., Kang J.J., Sipos A., Vargas S., Bansal E., Hanner F., Meer E., Peti-Peterdi J. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J. Clin. Invest. 2008, 118:2526-2534.
34. Vargas S.L., Toma I., Kang J.J., Meer E.J., Peti-Peterdi J. Activation of the succinate receptor GPR91 in macula densa cells causes renin release. J. Am. Soc. Nephrol. 2009, 20:1002-1011.
35. Wang H., Wittchen E.S., Jiang Y., Ambati B., Grossniklaus H.E., Hartnett M.E. Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signaling. Invest. Ophthalmol. Vis. Sci. 2011, 52:8271-8277.
36. Wang J., Xu X., Elliott M.H., Zhu M., Le Y.Z. Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 2010, 59:2297-2305.
37. Wu Y., Feng B., Chen S., Chakrabarti S. ERK5 regulates glucose-induced increased fibronectin production in the endothelial cells and in the retina in diabetes. Invest. Ophthalmol. Vis. Sci. 2012, 53:8405-8413.
38. Ye X., Ren H., Zhang M., Sun Z., Jiang A.C., Xu G. ERK1/2 signaling pathway in the release of VEGF from Muller cells in diabetes. Invest. Ophthalmol. Vis. Sci. 2012, 53:3481-3489.
39. Zhang L., Liu H.J., Li T.J., Yang Y., Guo X.L., Wu M.C., Rui Y.C., Wei L.X. Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formation in vitro. Acta Pharmacol. Sin. 2008, 29:847-852.